Therapeutic effect of adenoviral vector-mediated GM-CSF gene transfer in lung antimycobacterial immunity in M. bovis BCG infected mice

Alena Singpiel (Hannover, Germany), Alena Singpiel, Julia Kramer, Regina Maus, Jennifer Stolper, Tobias Welte, Jack Gauldie, Martin Kolb, Ulrich A. Maus

Source: International Congress 2016 – Rifampicin resistance, MDRTB, and new drug treatments
Session: Rifampicin resistance, MDRTB, and new drug treatments
Session type: Poster Discussion
Number: 1918
Disease area: Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Alena Singpiel (Hannover, Germany), Alena Singpiel, Julia Kramer, Regina Maus, Jennifer Stolper, Tobias Welte, Jack Gauldie, Martin Kolb, Ulrich A. Maus. Therapeutic effect of adenoviral vector-mediated GM-CSF gene transfer in lung antimycobacterial immunity in M. bovis BCG infected mice. Eur Respir J 2016; 48: Suppl. 60, 1918

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
BCG vaccination in childhood is not related to pulmonary immunity against M. tuberculosis in adults
Source: International Congress 2014 – Tuberculosis: public health and primary prevention
Year: 2014



The protective effect of BCG vaccination against mycobacterium tuberculosis infection in children: A systematic review
Source: International Congress 2014 – Tuberculosis: public health and primary prevention
Year: 2014


Comparative lentiviral versus adenoviral gene transfer of GM-CSF to bone marrow-derived versus pulmonary macrophages of mice
Source: International Congress 2015 – Management of TB: a patient focus
Year: 2015

Utility of mycobacterium tuberculosis Rv0081-specific host gene expression to distinguish latent infection from active tuberculosis disease
Source: International Congress 2016 – Active and latent tuberculosis: biomarkers
Year: 2016

Evaluation of IFNgamma release assays for detection of cellular immunity towards M. tuberculosis and CMV in samples from deceased donors
Source: Annual Congress 2013 –Immunological diagnosis of tuberculosis and latent tuberculosis infection
Year: 2013

A novel TNF inhibitor does not compromise host immunity to mycobacterium tuberculosis and BCG infections and still protects from hepatitis
Source: Annual Congress 2009 - Clinical immunology of tuberculosis
Year: 2009

Combined phenotypical and functional analysis of M. tuberculosis specific immunity for diagnosing active infection and risk assessment in latently infected individuals
Source: International Congress 2014 – Future frontiers in the diagnosis of Mycobacterium tuberculosis infection
Year: 2014

Exploring the mechanisms of granuloma formation in vivo to prevent dissemination of a respiratory mycobacterium tuberculosis infection: A live imaging approach
Source: International Congress 2016 – Tuberculosis: immune responses of CD8+ T cells, value of interferon-gamma and other cytokines, Th2 responses, BCG, and biomarkers
Year: 2016

Impact of nasopharyngeal pneumococcal colonization on protective immunity against S. pneumoniae in mice
Source: International Congress 2015 – Advances from translational research in respiratory infections
Year: 2015

Early BCG vaccination is unrelated to pulmonary immunity against Mycobacterium tuberculosis in adults
Source: Eur Respir J 2014; 44: 1087-1090
Year: 2014


Unique cytokine profiles of CD4+T cell to Acr, HBHA and MDP-1 antigens in different clinical stage of mycobacterium tuberculosis infection
Source: International Congress 2014 – Future frontiers in the diagnosis of Mycobacterium tuberculosis infection
Year: 2014

Cellular and humoral immune response in non HIV infected tuberculous patients in Upper Egypt
Source: International Congress 2015 – Science and biomarkers in TB
Year: 2015



Utility of Th1-cell immune responses in differentiating active tuberculosis from latent tuberculosis infection
Source: International Congress 2014 – Tuberculosis: from diagnosis to therapy and prevention
Year: 2014


Glycopeptidolipids for evaluating the role of non-tuberculous mycobacteria in latent tuberculosis infection diagnosis
Source: Annual Congress 2013 –Non-tuberculous mycobacteria: clinical management
Year: 2013


Genetically modified Salmonella typhimurium (ST) for the intranasal vaccination against Mycobacterium tuberculosis (Mtb): In vitro and in vivo results from the sequella vaccine
Source: Eur Respir J 2002; 20: Suppl. 38, 11s
Year: 2002

TLR2 subfamily gene polymorphisms are associated with BCG osteitis after vaccination in newborns - a nationwide study from Finland
Source: International Congress 2014 – Tuberculosis: from diagnosis to therapy and prevention
Year: 2014


IL-4 subverts mycobacterial containment in Mycobacterium tuberculosis-infected human macrophages
Source: Eur Respir J, 54 (2) 1802242; 10.1183/13993003.02242-2018
Year: 2019



LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement
Source: Eur Respir J 2009; 33: 956-973
Year: 2009



Design of immunogenic multiepitopic mycobacterium tuberculosis peptides from genes selected using in vitro models of mycobacterial macrophage infection
Source: Eur Respir J 2007; 30: Suppl. 51, 493s
Year: 2007

LSC 2014 abstract - Influenza infection of human lung macrophages increases PDL1 expression via autologous IFNbeta
Source: International Congress 2014 – Immunology of respiratory infections
Year: 2014